newsfilter
← Latest News
Business Wire·

PhaseBio Names Jonathan Birchall as Chief Commercial Officer

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the appointment of Jonathan J. Birchall as Chief C